RT @eyeonfda: #FDA – safety label changes & postmarket study requirements 4 extended-release long-acting opioid analgesics – ow.ly/oJZuX
posted on September 12, 2013 by
Medicaid, Medicare, Health Reform Consultant, Speaker, Author
RT@eyeonfda: #FDA – safety label changes & po…
<span class="my_class">Piper</span> Report
- Medicare Episode-Based Payment Reform Demonstrations: GAO Review of Voluntary and Mandatory Models
- Use of Prescription Medicines Today and Forecasts for 2023: Valuable Market Insights from IQVIA
- Real-World Evidence in Medical Product Development: Drugs, Biologics, Diagnostics, and Devices
- Physician Practice Patterns and Perspectives on Change: Insights from National Survey
- Teen Hospital Stays for Childbirth: Latest National and State Specific Trends
- Opioid Recovery and Patient Access to Medication Assisted Treatment in Medicaid, Medicare Part D, and Private Health Insurance